A month has gone by since the last earnings report for Icon PLC (ICLR). Shares have lost about 8.9% in that time frame, underperforming the S&P 500. Will the recent negative trend continue leading up ...

Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, today announced that ICON plc, (NASDAQ: ICLR) a world-leading clinical research ...

NEW YORK, March 20, 2025--Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, today announced that ICON plc, (NASDAQ: ICLR ...

Investors in ICON plc ICLR need to pay close attention to the stock based ... Currently, ICON is a Zacks Rank #4 (Sell) in the Medical Services industry that ranks in the Top 32% of our Zacks Industry ...

NEW YORK, NY / ACCESS Newswire / March 17, 2025 / Bernstein Liebhard LLP:Do you, or did you, own shares of ICON plc (NASDAQ:ICLR)?Did you ...

For the fourth quarter of 2024, the Wasatch International Select Fund—Investor Class was down -4.70% but outperformed the ...

ICON plc is a world-leading healthcare intelligence and clinical ... including current economic and industry conditions. These statements are not guarantees of future performance or actual results, ...

ICON plc, et al., No. 25-cv-00763 ... their clinical studies in-house and away from CROs like ICON. Despite these industry trends, ICON repeatedly represented that client demand was robust ...

About ICON plc ICON plc is a world-leading healthcare ... including current economic and industry conditions. These statements are not guarantees of future performance or actual results, and ...

Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds ICON plc (“ICON” or the ... cost reduction measures and other industry funding limitations.